Super Refined™ PEG 300

Super Refined PEG

The Super Refined PEG range is a series of Super Refined polyethylene glycols, offering pharmaceutical formulators highly purified hydrophilic excipients that can enhance active and formulation stability. Croda’s proprietary Super Refining process removes polar impurities, eliminating their adverse interactions with active pharmaceutical ingredients (APIs). The Super Refined PEG range is particularly suitable for use in gelatin capsules, as Super Refining removes the impurities that cause gelatin cross-linking and impaired drug dissolution

Lenguaje: Inglés | Tipo: Fichas Técnicas | Tamaño: 644kb

Super Refined PEG 300

SUPER REFINED® PEG-300 NF is a low molecular weight, liquid member of the range of Super Refined polyethylene glycols, and as such, offers pharmaceutical formulators the advantages of Croda’s proprietary flash chromatography process and the benefits of a highly purified excipient. Super Refining is a technique that removes polar impurities, such as peroxide species, aldehydes and ketones. Removal of these polar impurities eliminates their adverse interaction with Active Pharmaceutical Ingredients (APIs), thereby, enhancing the stability of the drug and/or the vehicle itself. Croda has been supplying its range of highly purified Super Refined triglyceride oils to the pharmaceutical industry for many years.

Lenguaje: Inglés | Tipo: Fichas Técnicas | Tamaño: 180kb

High Purity Excipients

Looking to enhance the bioavailability, delivery and efficacy of your dosage form? Our high purity excipients optimise the stability of your API and the performance of your formulations.

Lenguaje: Inglés | Tipo: Publicaciones | Tamaño: 538.5kb

Topical Dosage Form Excipients

Topically applied medicines contained in oil and fat based systems were one of the first dosage-forms used by man. Due to their ready availability, animal fats were widely used initially, but eventually plant oils and waxes became the vehicles of choice for applying the medicinal principal to the skin. Today, there is a diverse group of materials available to deliver topically applied Active Pharmaceutical Ingredients (API). Many of the current excipients are ingredients isolated or modified from naturally occurring raw materials.

Lenguaje: Inglés | Tipo: Fichas Técnicas | Tamaño: 55.66kb

Super Refined PEG 300

Lenguaje: Portugués | Tipo: Fichas Técnicas | Tamaño: 78kb

FDA Eye, Ears & Nose

Lenguaje: Portugués | Tipo: Poster | Tamaño: 901kb

FDA Oral Chart

Lenguaje: Portugués | Tipo: Poster | Tamaño: 344kb

FDA Parenteral Chart

Lenguaje: Portugués | Tipo: Poster | Tamaño: 101kb

Topical Dosage Form Excipients

Lenguaje: Portugués | Tipo: Fichas Técnicas | Tamaño: 519kb

FDA Topical Chart

Lenguaje: Portugués | Tipo: Poster | Tamaño: 433kb

Super Refined PEG 300

Lenguaje: Español | Tipo: Fichas Técnicas | Tamaño: 152kb

Topical Dosage Form Excipients

Lenguaje: Español | Tipo: Fichas Técnicas | Tamaño: 138kb

FDA Parenteral

Lenguaje: Español | Tipo: Poster | Tamaño: 176kb

Solubility Guide - Optimising Formulation Success

As API solubility continues to present challenges for the pharmaceutical formulator, in order to address this we have determined the solubility of a range of actives in a number of our high purity excipients. This baseline of information can provide you, the scientist, with a clearer starting point for your development work. Within this solubility guide, the solubility of 12 drug actives was determined using a range of our excipients for the purpose of demonstrating our capabilities to solubilise APIs.

Lenguaje: Inglés | Tipo: Publicaciones | Tamaño: 830.21kb

Excipient Purity - API Stability

The choice of pharmaceutical excipients can play a critical role in enhancing formulation stability. At Croda, our highly purified ingredients are designed to reduce the risk of product degradation, improving the chances of successful formulation development.

Lenguaje: Inglés | Tipo: Publicaciones | Tamaño: 494kb

Oral Super Refined Flyer

Lenguaje: Inglés | Tipo: Flier | Tamaño: 557kb